Granzyme K is a driver of age-related tissue remodeling and functional decline independently of age-associated immune dysfunction.
Key claim: Granzyme K is a tissue-specific driver of age-related fibrosis and organ decline in mice whose deletion preserves kidney and liver function without reversing hallmarks of immune aging.
Abstract
Aging is characterized by progressive tissue and organ decline, with chronic low-grade inflammation (inflammaging) implicated as a central driver. Granzyme K (GzmK), a serine protease that is markedly upregulated in aged memory CD8T cells, is proposed to be a central mediator of both immune and organismal aging. Using young and aged GzmKmice, we showed that GzmK was dispensable for the major hallmarks of immune aging, including T cell dysfunction, but was a critical driver of age-related tissue decline. Despite persistent immune aging phenotypes, GzmK deficiency markedly attenuated organ aging, effectively uncoupling immune and tissue aging. In the kidney, this was associated with reduced complement deposition, whereas in the liver, improved function and reduced fibrosis occurred independently of complement, coinciding instead with increased decorin and reduced pro-fibrotic TGF-β signaling. These findings identify GzmK as a tissue-specific driver of organismal aging but not immune aging or systemic inflammaging.
Why this matters
[animal-model] Granzyme K deletion preserved kidney and liver function and reduced age-related fibrosis in mice without reversing measured T-cell aging hallmarks, showing that organ protection need not coincide with normalization of these immune-aging readouts. [mechanism-plausible] This separates a candidate tissue-damage effector from classical immunosenescence, but genetic deletion does not establish that inhibiting granzyme K after aging is underway would reproduce the protection or benefit humans.